Publications by authors named "V H Basavaraj"
Article Synopsis
- Basal cell carcinoma (BCC) is the most common type of primary skin cancer, with pigmented BCC being a rare variant that can resemble nodular melanoma (NM).
- A case is presented involving a 40-something woman with a hyperpigmented nodule on her cheek that looked like pigmented NM, but dermoscopy revealed distinct features.
- After initial biopsy showed signs of trichoepithelioma, complete excision confirmed it was pigmented BCC; awareness of this rare presentation is essential for proper diagnosis and management, especially in dark-skinned patients.
Role of C4d immunohistochemical marker in the diagnosis of bullous pemphigoid: A cross-sectional study.
Indian J Dermatol Venereol Leprol
August 2024
Objective To determine the diagnostic utility of C4d immunohistochemical marker in cases of bullous pemphigoid by calculating the sensitivity, specificity, positive predictive value and negative predictive value. Methods We conducted an exploratory study (retrospectively and prospectively) from January 2017 to June 2022. All direct immunofluorescence proven cases of bullous pemphigoid were included in the study while cases with inadequate tissue for immunohistochemistry studies were excluded.
View Article and Find Full Text PDFBackground & Objective: Head and Neck Squamous Cell Carcinoma (HNSCC) is a highly frequent malignancy worldwide and is also the leading cause of death. The prognosis for individuals with HNSCC remains dismal, with a five-year survival rate of less than 50%. The novel anti-PD-L1 immunotherapy is found to be promising, and immunohistochemistry (IHC) has been established as a reliable method for patient stratification.
View Article and Find Full Text PDFArticle Synopsis
- * This review focuses on the genetic and epigenetic factors that contribute to breast cancer-related lymphedema (BCRL), highlighting the challenges in effectively diagnosing and treating the condition.
- * The authors emphasize the need for further research on epigenetic pathways to create new therapies and improve outcomes for breast cancer survivors struggling with lymphedema.